Want to see HK:2348 full AI Analyst Report?

Dawnrays Pharmaceutical Holdings Ltd. (2348) Revenue

6 Followers

Dawnrays Pharmaceutical Holdings Ltd. Revenue

Dawnrays Pharmaceutical Holdings Ltd. had a revenue of 538.31M in the quarter ending Jun 30, 2026, with -10.35%. This bring the company's revenue in the last twelve months to 1.14B, Increased -7.48%. In the fiscal year ending Dec 31, 2025, Dawnrays Pharmaceutical Holdings Ltd. had annual revenue of 1.23B with 16.09% growth.

Revenue (ttm)

1.14B

Revenue Growth

6.55%

P/S Ratio

1.18

Revenue/Employee

HK$1,146,059

Employees

1,074

Market Cap

HK$1.45B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	1.23B	170.56M	+16.09%
Dec 31, 2024	1.06B	-90.84M	-7.89%
Dec 31, 2023	1.15B	-126.54M	-9.90%
Dec 31, 2022	1.28B	112.53M	+9.66%
Dec 31, 2021	1.17B	140.88M	+13.75%
Dec 31, 2020	1.02B	74.26M	+7.82%
Dec 31, 2019	950.01M	1.07M	+0.11%
Dec 31, 2018	948.94M	66.45M	+7.53%
Dec 31, 2017	882.48M	―	―